News of the WeekClinical Research

Flawed Cancer Study Leads to Shake-Up at University of Oklahoma

Science  04 Aug 2000:
Vol. 289, Issue 5480, pp. 706-707
DOI: 10.1126/science.289.5480.706

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

Allegations of lax safety procedures and flawed management in a clinical cancer trial have cost four researchers and administrators their jobs at the University of Oklahoma. They have also led to a temporary shutdown of 75 clinical trials at the university's Health Science Center in Tulsa and a sweeping overhaul of the school's process for approving human experiments. University officials emphasize that none of the roughly 100 patients involved in the 3-year-old study of an experimental cancer vaccine was known to have been harmed, and that most trials will soon be restarted.

Related Content